Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period en
Melissa B. Cummings disposed of 3,437 shares for a total value of ~$109,000 on July 14, 2026. The transaction reduced the insider's direct equity holdings by 5%.
JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions and solid fundamentals amid market uncertainty.
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes Progyny (PGNY) a New Strong Buy Stock

01:01pm, Thursday, 09'th Jul 2026
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CFO Mark Livingston sold 8,275 shares for a transaction value of ~$211,000 on May 20, 2026. This represented 9.47% of Livingston's direct holdings, reducing his direct position to 79,063 shares.
On June 12, 2026, Progyny Inc (PGNY) shares rose 3.8% to $26.63. The stock has traded within a 52-week range of $16.10 to $28.75, indicating considerable volati
Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings.
Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience Patients increasingly say human connection and advocacy are essential to redu
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Board of Directors has approved a sha
On May 21, 2026, Progyny Inc (PGNY) shares fell 3.8%, closing at $24.69. This decline comes amidst a 52-week range where the stock has seen a high of $28.75 and
Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE